Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.35% |
| 2 | Energy | 10.93% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.18% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Diamondback Energy
FANG
$57.1B
| $53.1M | 0.1% |
822,168
-549,541
| -40% | -$37.3M |
|
227
Mohawk Industries
MHK
$7.5B
| $52.8M | 0.1% |
290,179
-120,795
| -29% | -$23.9M |
|
228
Neurocrine Biosciences
NBIX
$16.8B
| $52.7M | 0.1% |
1,325,374
+168,487
| +15% | +$8.14M |
|
|
CTXS
229
DELISTED
Citrix Systems Inc
CTXS
| $52.4M | 0.1% |
949,289
-68,816
| -7% | -$3.92M |
|
|
FOLD
230
DELISTED
Amicus Therapeutics
FOLD
| $52.2M | 0.1% |
3,734,506
-1,285,196
| -26% | -$20.2M |
|
231
Ultragenyx Pharmaceutical
RARE
$2.45B
| $52.2M | 0.1% |
541,689
+57,509
| +12% | +$6.58M |
|
232
Highwoods Properties
HIW
$3.65B
| $51.9M | 0.1% |
1,340,326
+716,387
| +115% | +$28.8M |
|
|
CPHD
233
DELISTED
Cepheid Inc
CPHD
| $51.5M | 0.1% |
1,139,419
+1,009,343
| +776% | +$53.9M |
|
234
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $51.4M | 0.1% |
2,604,244
+605,338
| +30% | +$12.5M |
|
235
CALL
H&R Block
HRB
$5.58B
| $51.4M | 0.1% |
+1,420,000
| New | +$48.1M |
|
|
INXN
236
DELISTED
Interxion Holding N.V.
INXN
| $51.1M | 0.1% |
1,888,562
-544,936
| -22% | -$15.1M |
|
237
Steel Dynamics
STLD
$36B
| $50.9M | 0.1% |
2,962,651
+1,496,014
| +102% | +$29M |
|
|
SLCA
238
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $50.8M | 0.1% |
3,607,037
+1,585,766
| +78% | +$33.8M |
|
239
PG&E
PCG
$38.3B
| $50.4M | 0.1% |
954,590
+221,790
| +30% | +$11.3M |
|
|
FITB
240
Fifth Third Bancorp
FITB
$51.2B
| $50.3M | 0.1% |
2,659,982
-2,178,452
| -45% | -$44.3M |
|
241
Align Technology
ALGN
$12.1B
| $50.2M | 0.1% |
883,843
-15,625
| -2% | -$932K |
|
|
LPT
242
DELISTED
Liberty Property Trust
LPT
| $49.9M | 0.1% |
1,583,708
+1,181,198
| +293% | +$38.4M |
|
243
Sysco
SYY
$40.8B
| $49.6M | 0.1% |
1,272,182
+1,105,209
| +662% | +$42.2M |
|
244
Acadia Healthcare
ACHC
$2.76B
| $49.4M | 0.1% |
744,968
+83,559
| +13% | +$6.43M |
|
245
Archrock
AROC
$6.27B
| $49.3M | 0.1% |
2,741,593
+785,382
| +40% | +$18.8M |
|
|
ALDR
246
DELISTED
Alder Biopharmaceuticals
ALDR
| $49.3M | 0.1% |
1,505,099
+32,674
| +2% | +$1.39M |
|
247
NVIDIA
NVDA
$4.86T
| $49.2M | 0.1% |
+79,893,240
| New | +$43.2M |
|
|
SF
248
Stifel
SF
$12.6B
| $49.1M | 0.1% |
2,625,950
+2,265,790
| +629% | +$51.3M |
|
|
EMC
249
DELISTED
EMC CORPORATION
EMC
| $48.3M | 0.09% |
1,999,476
+619,689
| +45% | +$15.7M |
|
250
Affiliated Managers Group
AMG
$9.69B
| $48M | 0.09% |
280,954
+271,464
| +2,861% | +$53.4M |
|
Similar funds
Millennium Management's Q3 2015 Portfolio in Review
As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Millennium Management opened 840 new positions and closed 681 in Q3 2015.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.